TRACEY BARNHART: Open Payments
NPI 1164440723 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 33 payments from 15 companies in 2025. Trend: 2023 $316 · 2024 $670 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $152 |
| ABBVIE INC. | 3 | $101 |
| Amgen Inc. | 4 | $70 |
| Lilly USA, LLC | 3 | $51 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Astellas Pharma US Inc | 1 | $30 |
| Exact Sciences Corporation | 1 | $25 |
| Boston Scientific Corporation | 1 | $23 |
Products named: QULIPTA, Wegovy, EVENITY, TZIELD, MOUNJARO, Ozempic, SHINGRIX, Veozah.
Industry payments across GA — which companies pay providers there.
